Hiroya Tange

Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice

S. Mizuta, D. Ishibashi, Takeshi Ishikawa, 2020, Neurotherapeutics.

Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection

T. Homma, R. Atarashi, N. Yamaguchi, 2021, Neuroscience Research.

Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice

S. Mizuta, D. Ishibashi, Takeshi Ishikawa, 2020, Neurotherapeutics.

Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice

K. Satoh, Tsuyoshi Mori, R. Atarashi, 2020, Neurotherapeutics.

Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro

D. Ishibashi, Yuzuru Taguchi, N. Nishida, 2020, bioRxiv.

Liquid–liquid phase separation of full-length prion protein initiates conformational conversion in vitro

D. Ishibashi, Yuzuru Taguchi, N. Nishida, 2020, bioRxiv.